Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 366

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 366
---
 Predecessor.

F-43

|                                                                                    |     | Convertible     
 Preferred Stock 
 Series A        
 Shares          |        |     | Amount |           |     | Series A     
 Common Stock 
 Shares       |       |   |     | Amount |   |     | Additional 
 Paid-in    
 Capital    |            |   |     | Stock        
 Subscription 
 Receivable   |            |   |     | Accumulated 
 Deficit     |             |   |     | Total |             |   |
|:-----------------------------------------------------------------------------------|:----|:----------------|-------:|:----|:-------|----------:|:----|:-------------|------:|:--|:----|:-------|--:|:----|:-----------|-----------:|:--|:----|:-------------|:-----------|:--|:----|:------------|:------------|:--|:----|:------|------------:|:--|
| PBAX Closing Equity as of February 13, 2024                                        |     |                 |      - |     | $      |         - |     |              | 2,741 |   |     | $      | - |     | $          |        547 |   |     | $            | -          |   |     | $           | (12,709,426 | ) |     | $     | (12,708,879 | ) |
| Forfeiture of founders shares                                                      |     |                 |      - |     |        |         - |     |              |  (438 | ) |     |        | - |     |            |          - |   |     |              | -          |   |     |             | -           |   |     |       |           - |   |
| Adjusted shares outstanding                                                        |     |                 |      - |     |        |         - |     |              | 2,303 |   |     |        | - |     |            |        547 |   |     |              | -          |   |     |             | (12,709,426 | ) |     |       | (12,708,879 | ) |
| Shares issued as consideration in the Merger                                       |     |                 |      - |     |        |         - |     |              | 4,038 |   |     |        | 1 |     |            | 47,238,749 |   |     |              | -